Farber HW - Search Results

1

Perspectives on oral pulmonary hypertension therapies recently approved by the U.S. Food and Drug Administration.

Hill NS, Badesch D, Benza RL, D'Eletto TA, Farber HW, Gomberg-Maitland M, Hassoun PM, Preston I. Hill NS, et al. Among authors: farber hw. Ann Am Thorac Soc. 2015 Feb;12(2):269-73. doi: 10.1513/AnnalsATS.201501-020AS. Ann Am Thorac Soc. 2015. PMID: 25590376

2

Effect of an endurance triathlon on pulmonary function.

Hill NS, Jacoby C, Farber HW. Hill NS, et al. Among authors: farber hw. Med Sci Sports Exerc. 1991 Nov;23(11):1260-4. Med Sci Sports Exerc. 1991. PMID: 1766341

3

The endurance triathlon: metabolic changes after each event and during recovery.

Farber HW, Schaefer EJ, Franey R, Grimaldi R, Hill NS. Farber HW, et al. Med Sci Sports Exerc. 1991 Aug;23(8):959-65. Med Sci Sports Exerc. 1991. PMID: 1956272

4

Effects of endothelial cell injury on pulmonary vascular reactivity.

Rounds S, Farber HW, Hill NS, O'Brien RF. Rounds S, et al. Among authors: farber hw. Chest. 1985 Oct;88(4 Suppl):213S-216S. doi: 10.1378/chest.88.4_supplement.213s. Chest. 1985. PMID: 3930163

5

Systemic sclerosis-associated pulmonary hypertension: short- and long-term effects of epoprostenol (prostacyclin).

Klings ES, Hill NS, Ieong MH, Simms RW, Korn JH, Farber HW. Klings ES, et al. Among authors: farber hw. Arthritis Rheum. 1999 Dec;42(12):2638-45. doi: 10.1002/1529-0131(199912)42:12<2638::AID-ANR20>3.0.CO;2-X. Arthritis Rheum. 1999. PMID: 10616012 Free article.

6

Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension.

Aguilar RV, Farber HW. Aguilar RV, et al. Among authors: farber hw. Am J Respir Crit Care Med. 2000 Nov;162(5):1846-50. doi: 10.1164/ajrccm.162.5.2004042. Am J Respir Crit Care Med. 2000. PMID: 11069824

7

HIV-associated pulmonary hypertension.

Farber HW. Farber HW. AIDS Clin Care. 2001 Jun;13(6):53-5, 59. AIDS Clin Care. 2001. PMID: 11710309 No abstract available.

8

The pathogenesis of HIV-associated pulmonary hypertension.

Klings ES, Farber HW. Klings ES, et al. Among authors: farber hw. Adv Cardiol. 2003;40:71-82. doi: 10.1159/000073176. Adv Cardiol. 2003. PMID: 14533547 Review. No abstract available.

9

HIV-associated pulmonary hypertension: diagnosis and treatment.

Burkart KM, Farber HW. Burkart KM, et al. Among authors: farber hw. Adv Cardiol. 2003;40:197-207. doi: 10.1159/000073184. Adv Cardiol. 2003. PMID: 14533555 Review. No abstract available.

10

Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension.

Preston IR, Klinger JR, Houtches J, Nelson D, Farber HW, Hill NS. Preston IR, et al. Among authors: farber hw. Respir Med. 2005 Dec;99(12):1501-10. doi: 10.1016/j.rmed.2005.03.026. Respir Med. 2005. PMID: 15890512 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

253 results

Search Page

Filters